Based on the RadNet Inc stock forecast from 3 analysts, the average analyst target price for RadNet Inc is USD 79.33 over the next 12 months. RadNet Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of RadNet Inc is Neutral, which is based on 7 positive signals and 7 negative signals. At the last closing, RadNet Inc’s stock price was USD 73.36. RadNet Inc’s stock price has changed by +1.31% over the past week, -9.95% over the past month and +108.41% over the last year.
No recent analyst target price found for RadNet Inc
No recent average analyst rating found for RadNet Inc
Company Overview RadNet Inc
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California. Read Less
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron em...Read More
Frequently Asked Questions About RadNet Inc (RDNT) Stock
Based on ratings from 3 analysts RadNet Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Neutral. The stock has 8 buy, sell and 1 hold ratings.
Unfortunately we do not have enough data on RDNT's stock to indicate if its a good dividend stock.
Based on targets from 3 analysts, the average taret price for RDNT is USD 79.33 over the next 12 months. The maximum analyst target price is USD 100 while the minimum anlayst target price is USD 51.
RDNT stock's Price/Earning ratio is 370.89.
Our analysis grades RDNT stock's Price / Earning ratio at F. This means that RDNT stock's Price/Earning ratio is above 91% of the stocks in the Diagnostics & Research sector in the NSD exchange.
Based on this RDNT may be a overvalued for its sector.
The last closing price of RDNT's stock was USD 73.36.
The most recent market capitalization for RDNT is USD 6.04B.
Based on targets from 3 analysts, the average taret price for RDNT is projected at USD 79.33 over the next 12 months.
This means that RDNT's stock price may go up by +8.14% over the next 12 months.
We can't find any ETFs which contains RadNet Inc's stock.
As per our most recent records RadNet Inc has 10,000 Employees.
RadNet Inc's registered address is 1510 Cotner Avenue, Los Angeles, CA, United States, 90025.
You can get more information about it from RadNet Inc's website at https://www.radnet.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About RadNet Inc (RDNT) Stock
Based on ratings from 3 analysts RadNet Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Neutral. The stock has 8 buy, sell and 1 hold ratings.
Unfortunately we do not have enough data on RDNT's stock to indicate if its a good dividend stock.
Based on targets from 3 analysts, the average taret price for RDNT is USD 79.33 over the next 12 months. The maximum analyst target price is USD 100 while the minimum anlayst target price is USD 51.
RDNT stock's Price/Earning ratio is 370.89.
Our analysis grades RDNT stock's Price / Earning ratio at F. This means that RDNT stock's Price/Earning ratio is above 91% of the stocks in the Diagnostics & Research sector in the NSD exchange.
Based on this RDNT may be a overvalued for its sector.
The last closing price of RDNT's stock was USD 73.36.
The most recent market capitalization for RDNT is USD 6.04B.
Based on targets from 3 analysts, the average taret price for RDNT is projected at USD 79.33 over the next 12 months.
This means that RDNT's stock price may go up by +8.14% over the next 12 months.
We can't find any ETFs which contains RadNet Inc's stock.
As per our most recent records RadNet Inc has 10,000 Employees.
RadNet Inc's registered address is 1510 Cotner Avenue, Los Angeles, CA, United States, 90025.
You can get more information about it from RadNet Inc's website at https://www.radnet.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for RDNT !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
